Literature DB >> 15258207

Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline.

M C Morris1, D A Evans, J L Bienias, P A Scherr, C C Tangney, L E Hebert, D A Bennett, R S Wilson, N Aggarwal.   

Abstract

BACKGROUND: Dementia can be caused by severe niacin insufficiency, but it is unknown whether variation in intake of niacin in the usual diet is linked to neurodegenerative decline. We examined whether dietary intake of niacin was associated with incident Alzheimer's disease (AD) and cognitive decline in a large, prospective study.
METHODS: This study was conducted in 1993-2002 in a geographically defined Chicago community of 6158 residents aged 65 years and older. Nutrient intake was determined by food frequency questionnaire. Four cognitive tests were administered to all study participants at 3 year intervals in a 6 year follow up. A total of 3718 participants had dietary data and at least two cognitive assessments for analyses of cognitive change over a median 5.5 years. Clinical evaluations were performed on a stratified random sample of 815 participants initially unaffected by AD, and 131 participants were diagnosed with 4 year incident AD by standardised criteria.
RESULTS: Energy adjusted niacin intake had a protective effect on development of AD and cognitive decline. In a logistic regression model, relative risks (95% confidence intervals) for incident AD from lowest to highest quintiles of total niacin intake were: 1.0 (referent) 0.3 (0.1 to 0.6), 0.3 (0.1 to 0.7), 0.6 (0.3 to 1.3), and 0.3 (0.1 to 0.7) adjusted for age, sex, race, education, and ApoE e4 status. Niacin intake from foods was also inversely associated with AD (p for linear trend = 0.002 in the adjusted model). In an adjusted random effects model, higher food intake of niacin was associated with a slower annual rate of cognitive decline, by 0.019 standardised units (SU) per natural log increase in intake (mg) (p = 0.05). Stronger associations were observed in analyses that excluded participants with a history of cardiovascular disease (beta = 0.028 SU/year; p = 0.008), those with low baseline cognitive scores (beta = 0.023 SU/year; p = 0.02), or those with fewer than 12 years' education (beta = 0.035 SU/year; p = 0.002)
CONCLUSION: Dietary niacin may protect against AD and age related cognitive decline.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258207      PMCID: PMC1739176          DOI: 10.1136/jnnp.2003.025858

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  35 in total

1.  Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Authors:  Sudha Seshadri; Alexa Beiser; Jacob Selhub; Paul F Jacques; Irwin H Rosenberg; Ralph B D'Agostino; Peter W F Wilson; Philip A Wolf
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

2.  Neuropsychological and neurophysiological changes in healthy adult humans across the age range.

Authors:  M Albert
Journal:  Neurobiol Aging       Date:  1993 Nov-Dec       Impact factor: 4.673

Review 3.  Niacin, poly(ADP-ribose) polymerase-1 and genomic stability.

Authors:  G J Hageman; R H Stierum
Journal:  Mutat Res       Date:  2001-04-18       Impact factor: 2.433

4.  Lipid peroxidation in nicotinamide-deficient and nicotinamide-supplemented rats.

Authors:  S S Melo; M S Meirelles; A A Jordão Júnior; H Vannucchi
Journal:  Int J Vitam Nutr Res       Date:  2000-12       Impact factor: 1.784

5.  Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury.

Authors:  Zhao Zhong Chong; Shi-Hua Lin; Kenneth Maiese
Journal:  J Vasc Res       Date:  2002 Mar-Apr       Impact factor: 1.934

6.  Vitamin B(12) and folate in relation to the development of Alzheimer's disease.

Authors:  H X Wang; A Wahlin ; H Basun; J Fastbom; B Winblad; L Fratiglioni
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

7.  Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease.

Authors:  M Albert; L A Smith; P A Scherr; J O Taylor; D A Evans; H H Funkenstein
Journal:  Int J Neurosci       Date:  1991-04       Impact factor: 2.292

8.  Dietary intake of antioxidants and risk of Alzheimer disease.

Authors:  Marianne J Engelhart; Mirjam I Geerlings; Annemieke Ruitenberg; John C van Swieten; Albert Hofman; Jacqueline C M Witteman; Monique M B Breteler
Journal:  JAMA       Date:  2002-06-26       Impact factor: 56.272

9.  Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study.

Authors:  Martha Clare Morris; Denis A Evans; Julia L Bienias; Christine C Tangney; David A Bennett; Neelum Aggarwal; Robert S Wilson; Paul A Scherr
Journal:  JAMA       Date:  2002-06-26       Impact factor: 56.272

10.  Response to a mail nutritional survey in an older bi-racial community population.

Authors:  M C Morris; G A Colditz; D A Evans
Journal:  Ann Epidemiol       Date:  1998-07       Impact factor: 3.797

View more
  31 in total

Review 1.  Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease.

Authors:  Dimitrios Kapogiannis; Mark P Mattson
Journal:  Lancet Neurol       Date:  2010-12-10       Impact factor: 44.182

Review 2.  Thoughts on B-vitamins and dementia.

Authors:  Martha Clare Morris; Julie A Schneider; Christine C Tangney
Journal:  J Alzheimers Dis       Date:  2006-08       Impact factor: 4.472

Review 3.  The impact of nutrition on cognition in the elderly.

Authors:  Kathleen Van Dyk; Mary Sano
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

4.  Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease.

Authors:  Martha Clare Morris; Denis A Evans; Julie A Schneider; Christine C Tangney; Julia L Bienias; Neelum T Aggarwal
Journal:  J Alzheimers Dis       Date:  2006-08       Impact factor: 4.472

Review 5.  Vitamins Associated with Brain Aging, Mild Cognitive Impairment, and Alzheimer Disease: Biomarkers, Epidemiological and Experimental Evidence, Plausible Mechanisms, and Knowledge Gaps.

Authors:  Michael Fenech
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

6.  N2L, a novel lipoic acid-niacin dimer protects HT22 cells against β-amyloid peptide-induced damage through attenuating apoptosis.

Authors:  Rikang Wang; Lang Zhang; Rifang Liao; Qian Li; Rongbiao Pi; Xiaobo Yang
Journal:  Metab Brain Dis       Date:  2019-09-02       Impact factor: 3.584

Review 7.  Peanuts as functional food: a review.

Authors:  Shalini S Arya; Akshata R Salve; S Chauhan
Journal:  J Food Sci Technol       Date:  2015-09-19       Impact factor: 2.701

8.  Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline.

Authors:  Christine C Tangney; Yuxiao Tang; Denis A Evans; Martha Clare Morris
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

Review 9.  Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature.

Authors:  Christianna Purnell; Sujuan Gao; Christopher M Callahan; Hugh C Hendrie
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

Review 10.  The vitamin nicotinamide: translating nutrition into clinical care.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Molecules       Date:  2009-09-09       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.